Search for: "PFIZER"
Results 1441 - 1460
of 4,632
Sort by Relevance
|
Sort by Date
16 Feb 2016, 8:00 am
Pfizer Laboratories Division, 216 Ill.App.3d 360 (1991). [read post]
16 Feb 2016, 8:00 am
Pfizer Laboratories Division, 216 Ill.App.3d 360 (1991). [read post]
15 Feb 2016, 9:59 pm
By Donald Zuhn -- Last month, in Pfizer, Inc. v. [read post]
14 Feb 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law Two whistleblowers brought suit against Pfizer’s Wyeth Pharmaceutical Inc. [read post]
14 Feb 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law Two whistleblowers brought suit against Pfizer’s Wyeth Pharmaceutical Inc. [read post]
10 Feb 2016, 6:04 am
The “mega-deal” made a big comeback, with a record 69 deals over $10 billion, and 10 deals over $50 billion, including two of the largest on record: Pfizer’s $160 billion agreement to acquire Allergan and Anheuser-Busch InBev’s $117 billion bid for SABMiller. [read post]
10 Feb 2016, 6:04 am
The “mega-deal” made a big comeback, with a record 69 deals over $10 billion, and 10 deals over $50 billion, including two of the largest on record: Pfizer’s $160 billion agreement to acquire Allergan and Anheuser-Busch InBev’s $117 billion bid for SABMiller. [read post]
9 Feb 2016, 6:27 am
Pfizer, Inc., 2000 WL 1738645 (S.D.N.Y. [read post]
3 Feb 2016, 4:00 am
Wyeth and Pfizer Canada Inc., 2011 FC 1169 at 34 reversed on other grounds 2012 FCA 141, Louis Vuitton Malletier S.A. v. [read post]
29 Jan 2016, 7:14 am
Pfizer argued that the original restriction requirement, because it was incomplete, created a delay by failing to provide Pfizer with adequate notice of the basis for rejecting its claims. [read post]
29 Jan 2016, 7:14 am
Pfizer argued that the original restriction requirement, because it was incomplete, created a delay by failing to provide Pfizer with adequate notice of the basis for rejecting its claims. [read post]
28 Jan 2016, 3:03 pm
Pfizer may have got a lucky break in the Lipitor multidistrict litigation (MDL). [read post]
28 Jan 2016, 9:02 am
Patent Term Adjustment (PTA) is utilized by the Patent Office so that an inventor’s patent protection is not limited by delays caused by the Patent Office. [read post]
28 Jan 2016, 6:03 am
In October 2015, press reports began appearing suggesting that Pfizer Inc., one of the world’s largest pharmaceutical companies, and Allergan, an Irish publicly traded pharmaceutical company, were considering entering into the largest inversion in history. [read post]
24 Jan 2016, 8:00 am
There is a bit of movement in this week's list of the Top 5 Recent Tax Paper Downloads, with a new paper debuting on the list at #5: [346 Downloads] The Three Causes of Inversions: Reflections on Pfizer/Allergan and Notice 2015-79, by Reuven Avi-Yonah (Michigan) [288 Downloads] Conservation Easements and... [read post]
24 Jan 2016, 6:11 am
, lawsuits are swarming around the creators of the drugs (Bristol-Myers Squibb and Otsuka Pharmaceuticals for Abilify, Pfizer and Boehringer Ingelheim for Mirapex). [read post]
22 Jan 2016, 1:40 pm
The CAFC affirmed ED Va and noted general issues with 35 U.S.C. [read post]
22 Jan 2016, 8:02 am
By Dennis Crouch Pfizer v. [read post]
21 Jan 2016, 12:50 pm
Pfizer, Inc.], 153 S.W.3d [758,] 763–64 [(Ky. 2004)].Watts v. [read post]
21 Jan 2016, 12:08 pm
Pfizer, Inc.], 153 S.W.3d [758,] 763–64 [(Ky. 2004)]. [read post]
